Generics

Filter

Current filters:

None

Popular Filters

40 to 64 of 1136 results

Cambrex to invest $45-$50 million in API capacity expansion; posts strong financials

06-02-2015

US drugmaker Cambrex has initiated the second significant expansion of its Charles City, Iowa, facility…

CambrexFinancialGenericsProduction

Orexo files US patent infringement law suit against Actavis for Abstral

Orexo files US patent infringement law suit against Actavis for Abstral

06-02-2015

Sweden-based pharma company Orexo has filed a patent infringement law suit in the US District Court for…

AbstralActavisAnalgesiaGenericsLegalOrexoUSA

UPDATE: Pfizer to acquire Hospira for around $17 billion

UPDATE: Pfizer to acquire Hospira for around $17 billion

05-02-2015

US pharma giant Pfizer has entered into a definitive merger agreement to acquire Hospira, news of which…

BiosimilarsGenericsHospiraMergers & AcquisitionsPfizer

Generics will limit growth in French pharma market, says report

Generics will limit growth in French pharma market, says report

04-02-2015

The French pharmaceutical market is forecast to grow at a tepid compound annual growth rate (CAGR) of…

FranceGenericsMarkets & Marketing

Mylan to acquire certain women’s health businesses from Famy Care

Mylan to acquire certain women’s health businesses from Famy Care

02-02-2015

US generics drugmaker Mylan has signed a definitive agreement to acquire certain female health care businesses…

GenericsIndiaMergers & AcquisitionsMylanWomen's Health

CPhI Worldwide experts make pharma predictions for 2015

30-01-2015

CPhI Worldwide, organized by UBM EMEA, has delivered its expert panel forecast for the pharmaceutical…

GenericsMarkets & MarketingProduction

European Commission clears Mylan acquisition of Abbott's European generics business

European Commission clears Mylan acquisition of Abbott's European generics business

29-01-2015

The European Commission has cleared the proposed acquisition of Abbott Laboratories’ non-US developed…

Abbott LaboratoriesEuropeGenericsMergers & AcquisitionsMylan

US FDA approves first generic of AstraZeneca’s Nexium

US FDA approves first generic of AstraZeneca’s Nexium

27-01-2015

The US Food and Drug Administration yesterday approved a generic version of Nexium (esomeprazole), Anglo-Swedish…

AstraZenecaGastro-intestinalsGenericsNexiumRegulationTeva Pharmaceutcal IndustriesUSA

Actavis to acquire UK generics firm Auden Mckenzie

26-01-2015

Ireland-headquartered generic major Actavis said today that it has reached agreement to acquire UK-based…

ActavisAuden MckenzieGenericsMergers & AcquisitionsUK

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

Supernus sues TWi for infringement of Oxtellar XR patents

22-01-2015

US drugmaker Supernus Pharmaceuticals says that it has sued generic drug makers Taiwan-based TWi Pharmaceuticals…

GenericsLegalNeurologicalOxtellar XRPatentsSupernus PharmaceuticalsTWi PharmaceuticalsUSA

New phase of MAb biosimilars opportunities in Japan

New phase of MAb biosimilars opportunities in Japan

21-01-2015

The launch of Remicade (infliximab, from Johnson & Johnson) biosimilar in December 2014 in the Japan…

BiosimilarserythropoietinGenericsJapanMarkets & MarketingRegulationRemicade

Strides Arcolab to make and distribute Gilead’s TAF

20-01-2015

Indian drugmaker Strides Arcolab Limited has entered into a licensing agreement with US biotech major…

Anti-viralsGenericsGilead SciencesLicensingProductionStrides Arcolabtenofovir alafenamide

EMA to boost international cooperation on generics

EMA to boost international cooperation on generics

19-01-2015

The European Medicines Agency is ready to share its assessments of applications for generic medicines…

EuropeGenericsGlobalRegulation

Supernus sues Par for Trokendi XR patents infringement

19-01-2015

US drugmaker Supernus Pharmaceuticals says it has sued privately-held generics firm Par Pharmaceutical…

GenericsLegalNeurologicalPar PharmaceuticalsPatentsSupernus PharmaceuticalsTrokendi XRUSA

Akorn files ANDA for generic Durezol

16-01-2015

US generic drugmaker Akorn has confirmed that it has filed an Abbreviated New Drug Application (ANDA)…

AkornAlconDurezolGenericsNovartisOphthalmicsPatentsRegulationUSA

AMRI to develop parenteral drug products with Genovi

13-01-2015

Albany Molecular Research has entered into several development and supply agreements with the UK’s…

Albany Molecular ResearchEuropeGenericsGenovi PharmaceuticalsMarkets & MarketingProductionUSA

Helsinn settles with Sandoz over Aloxi in USA

12-01-2015

Privately-held Swiss cancer specialist Helsinn Group say it has entered into a settlement agreement with…

AloxiEisaiGenericsHelsinn GroupLegalNovartisOncologyPatentsSandozUSA

Health Canada instigates quarantine of products from Sri Krishna Pharmaceuticals

Health Canada instigates quarantine of products from Sri Krishna Pharmaceuticals

07-01-2015

At Health Canada's request, Canadian importers have agreed to quarantine health products made with active…

CanadaGenericsIndiaItalyRegulationSri Krishna Pharmaceuticals

Russian government takes steps to prevent further drug price increases

Russian government takes steps to prevent further drug price increases

05-01-2015

The Russian government is designing a number of measures aimed at preventing a further increase of drug…

GenericsPricingRussia

40 to 64 of 1136 results

Back to top